Abstract
Insect diuretic hormones are crucial for control of water balance. We isolated from the cockroach Diploptera punctata two diuretic hormones (DH), Dippu-DH31 and Dippu-DH46, which increase cAMP production and fluid secretion in Malpighian tubules of several insect species. Dippu-DH31 and -DH46 contain 31 and 46 amino acids, respectively. Dippu-DH46 belongs to the corticotropin-releasing factor (CRF)-like insect DH family, whereas Dippu-DH31 has little sequence similarity to the CRF-like DH, but is similar to the calcitonin family. Dippu-DH46 and -DH31 have synergistic effects in D. punctata but have only additive effects in Locusta migratoria. Dippu-DH31 represents a distinct type of insect DH with actions that differ from those of previously identified insect peptides with diuretic activity.
Keywords: Malpighian tubules, corticotropin-releasing factor, Diploptera punctata, Locusta migratoria, Manduca sexta
In insects, urine production by the Malpighian tubules (Mt) is driven by hormonally controlled active transport processes, rather than by ultrafiltration, as in vertebrates. There are several families of insect diuretic peptides, including myokinins, which increase urine production by elevating intracellular Ca2+ (1, 2), and the “corticotropin-releasing factor (CRF)-like” diuretic hormones (DH), which act via cAMP (3). CRF-like DH have been identified from eight species in five insect orders (4–14); they are similar to the sauvagine/CRF/urotensin I/urocortin family of vertebrate peptides.
For some years, only Manduca sexta was known to possess two CRF-like DH, Manse-DH (4) and Manse-DPII (9). Manse-DPII is shorter (30 residues) than other known DH and has lower sequence similarity with other DH than does Manse-DH. However, in 1998, we identified a second DH from Tenebrio molitor, termed Tenmo-DH47 (12) to distinguish this peptide from the known Tenmo-DH37 (11). More recently we identified two DH from Hyles lineata (a sphingid moth closely related to M. sexta), Hylli-DH30 and Hylli-DH41, which each differ at only one residue from their M. sexta counterparts. Thus, in at least three insect species, two DH exist. The extent of sequence similarity between these “long” and “short” DH indicates that they belong to the same peptide family. However, they are most likely paralogous sequences (arising from a gene duplication event), as is the case for fish CRF and urotensin I. The lower potency of Tenmo-DH47 vs. Tenmo-DH37 (12) suggests for it a somewhat different role, just as urocortin, an orthologue of urotensin I (15), has effects that differ in vivo from those of CRF (16, 17).
We now report the identification of two DH from brain and corpora cardiaca (CC) of the Pacific beetle cockroach (Diploptera punctata), one of which (Dippu-DH31) is a peptide with biological properties that differ from those of the CRF-like DH.
Materials and Methods
Insects.
D. punctata were maintained as described previously (18). Brains and CC were dissected from adult males 2–10 days old. For bioassays, newly emerged adult males were isolated from the colony, and Mt were dissected (day 0). The M. sexta colony was reared essentially as described by Yamamoto (19). Newly emerged adult males (0–4 hr posteclosion) were chilled on ice for 15 min before dissection of Mt. Schistocerca americana were reared at 28°C on romaine lettuce with a 14-hr light/10-hr dark photoperiod. Locusta migratoria, taken from a colony at Birkbeck College, were reared under identical conditions but were fed fresh germinated wheat, with water provided ad libitum. The Mt were removed from decapitated 7- to 14-day-old adult female locusts.
Extraction of Brains and CC.
Brain/CC complexes (1,040) were extracted as described earlier (11), but the solvent was methanol containing 9.9% CH3CO2H, 0.1% (vol/vol) 2-(methylthio)ethanol, 20 mM H2SO4, 0.1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 0.01 mM pepstatin A, and 1.5 mg BSA. The mixture was additionally sonicated (5 min, 4°C). The supernatants from the extraction (11) were evaporated to half their volume and diluted with 200 ml of 0.1% trifluoroacetic acid (TFA).
Peptide Isolation.
Extracts were purified by step elution with 0.1% TFA, 20% CH3CN/0.1% TFA, 45% CH3CN/0.1% TFA, and 60% CH3CN/0.1% TFA through 5 g of Vydac (Hesperia, CA) C4 reversed-phase packing material (11). To each fraction eluted, 5 mg of BSA was added. Bioassays with Mt of M. sexta and S. americana revealed that diuretic activity, as determined by secretion of cAMP, was confined to a fraction eluted with 45% (vol/vol) acetonitrile/0.1% TFA. This solution was diluted with water, loaded onto a Vydac C18 RP-HPLC column, and eluted as given in the legend to Fig. 1. Fractions A and B were separately diluted with water and injected onto a Polymer Laboratories (Amherst, MA) PLRP-S (5 μm, 100 Å, 2.1 mm × 150 mm) column eluted at 200 μl/min with a gradient of acetonitrile (4–61%) in 0.1% TFA. After locating active fractions A and B, these were separately purified on a Reliasil (Column Engineering, Ontario, CA) C18 column (5 μm, 300 Å, 1.0 mm × 150 mm) eluted at 50 μl/min with a gradient of acetonitrile (4–61%) in 0.1% TFA.
Peptide Microanalysis and Synthesis.
Positive-ion electrospray ionization spectra of the samples were acquired as described (11) with a Finnigan-MAT (San Jose, CA) SSQ-710 mass spectrometer with Analytica (Branford, CT) electrospray source. Automated Edman degradation was performed with a Porton Instruments (Tarzana, CA) PI 2090 sequencer, a PE Biosystems (Foster City, CA) 494HT sequencer, or a Hewlett–Packard G1005A sequencer. Purified Dippu-DH31 (≈150 pmol) and -DH46 (≈100 pmol) were digested with lysyl endopeptidase (Wako BioProducts, Richmond, VA) and endoproteinase Asp-N (Boehringer Mannheim), respectively, and fractionated by RP-HPLC, and fragments were analyzed by electrospray ionization-MS. The C-terminal amide functionality was determined from the Mr 721.3 ± 0.1 fragment (DFLESI-NH2, from Dippu-DH46) and the 1341.1 ± 0.1 fragment (HLMGLAAANYAGGP-NH2, from Dippu-DH31), which agree with the calculated Mr of the amidated forms (721.35 and 1340.65, respectively); the masses of the C-terminal free acid forms are 0.98 atomic mass unit higher. Both putative DH were synthesized by using a PE Biosystems model 431A synthesizer using fluorenylmethoxycarbonyl protocols as reported (12, 20).
Bioassay for Isolation.
Samples containing 1–2 head equivalents were taken for in vitro (6) assays with Mt from M. sexta and S. americana. BSA (50 μg) was added to avoid loss of peptides. Aliquots were dried (vacuum centrifuge) and redissolved in 400 μl of saline (21) containing 0.5 mM 3-isobutyl-1-methylxanthine to inhibit phosphodiesterases. Batches of 10 Mt pieces (each ≈0.5 cm long) from S. americana or a single Mt fragment (≈1.0 cm) from M. sexta were added to 100-μl aliquots and incubated for 1 h. The cAMP released into 50 μl of medium was quantified as described (12).
Bioassay for Physiological Studies.
Ramsay assays (22) were conducted with modifications. For L. migratoria, complete details have been described elsewhere (23). Diuretic activity was calculated as the difference between fluid secretion rates (Δ nl/min) measured before and after the addition of stimulants to the bathing fluid, with each tubule serving as its own control. To reduce between-assay variability when constructing dose-response curves, peptides were tested alongside control tubules stimulated maximally with 50 nM Locmi-DH, and results were expressed as a percentage of the maximal rate of secretion achieved by using Locmi-DH. All experiments were performed at 22°C ± 3°C. In contrast, for D. punctata, diuretic activity was calculated as the difference between fluid secretion rates (nl/min) measured before and after the addition of stimulants to the bathing fluid and is expressed as the percentage stimulation, with each tubule serving as its own control. All experiments were performed at room temperature.
Measurement of Urine K+ and Na+ Concentrations.
Monovalent cation concentrations were measured by using a modified Corning flame photometer (model 410) as described (24). Urine K+ concentrations were measured in samples of about 15 nl, whereas samples of about 100 nl were needed for Na+ measurements. For unstimulated tubules, urine samples from 4–6 tubules were pooled for the measurement of Na+ and K+, but at high urine flow rates, both parameters could be measured on samples from 1 or 2 tubules.
Results
Isolation and Identification of the Peptides.
We measured DH activity in extracts by following cAMP secreted by isolated Mt from adult S. americana and from adult male M. sexta (0 to 4 hr posteclosion). The secretion of cAMP by insect Mt is well known and permits rapid assay for biological activity.
Frozen brains and CC dissected from ≈1,000 of the D. punctata adult males were extracted and purified by solid phase extraction using C4 silica packing, followed by RP-HPLC (11). Two fractions, A and B, (Fig. 1) stimulated cAMP production in Mt of S. americana. The level of cAMP released by Mt of M. sexta was elevated only by factor B. The Mt of M. sexta were more sensitive to factor B than those of S. americana; accordingly, we used M. sexta for bioassay of factor B in subsequent purifications. For factor A, Mt of S. americana were used. Active factors A and B were purified by using two more RP-HPLC separations; ≈0.5 nmol of each DH was obtained in pure form from 1,000 D. punctata brain and CC.
Electrospray ionization mass spectrometry showed DH from A and B to have Mr of 2,987.0 ± 0.2 and 5,322.0 ± 0.1, respectively. Edman microsequencing of intact peptides gave the complete sequence for factor B, but the C-terminal residue of factor A “washed off” in sequence analysis. We generated C-terminal fragments from both DH by digestion with specific proteases to generate smaller peptide fragments. These fragments were used to determine whether or not the C terminus was amidated and to identify the C-terminal amino acid of factor A. Mass spectral analysis of the two different C-terminal fragments yielded the following complete sequences: GLDLGLSRGFSGSQAAKHLMGLAAANYAGGP-NH2 and TGTGPSLSIVNPLDVLRQRLLLEIARRRMRQTQNMIQANRDFLESI-NH2. We named these peptides D. punctata DH 31 (Dippu-DH31) and -46 (Dippu-DH46). Both peptides were synthesized for structural confirmation and bioassay. Patel et al. (25) have presented “unequivocal evidence of a hormonal function” for the CRF-like DH from L. migratoria (Locmi-DH, Fig. 2, previously called Locusta DP). Although such evidence has not been explicitly provided for other members of the CRF-like DH, we feel justified in abbreviating these peptides as DH rather than DF (diuretic factor) or DP (diuretic peptide).
Dippu-DH46 is readily recognized as a member of the CRF-like DH family, with 83% identity to Peram-DH and 72% identity to Locmi-DH. However, Dippu-DH31 does not align with the CRF-like DH when the program clustal w is used. A blast search for sequence similarity revealed over 50 diverse proteins from a number of species with sequence identities from 15 to 8 of the 31 residues of Dippu-DH31, but found no peptide hormones. A manual search of the Peninsula Laboratories catalog of bioactive peptides revealed similarity to the sequence of calcitonin, in particular to the unusual Pro-amide C terminus. Therefore, we searched Swiss-Prot for calcitonin from a number of species and aligned the sequences with Dippu-DH31 (six identities, or 19%) by using clustal w; the results are shown in Fig. 2B.
Biological Evaluation of the Synthetic DH: Second-Messenger Assays.
Synthetic Dippu-DH31 stimulates cAMP production by Mt of S. americana in a dose-dependent manner (EC50 = 16 nM; maximal stimulation = 20 pmol of cAMP per tubule segment). Locmi-DH has a maximal stimulation of ≈100 pmol of cAMP on S. americana tubule segments, but Manse-DH has no detectable activity on these tubules despite its higher similarity to Locmi-DH (≈49% sequence identity) than to Dippu-DH31. The latter has only four residues in common with Locmi-DH in our alignment (Fig. 2A). Dippu-DH31 has no effect on production of cAMP by Mt of M. sexta, although they are stimulated by all known insect CRF-related DH (3) except Tenmo-DH37 and -DH47 (11), neither of which is amidated.
Biological Evaluation of the Synthetic DH: Fluid Secretion Assays.
Response of D. punctata Mt to Dippu-DH31 and -DH46.
Synthetic Dippu-DH31 and -DH46 were tested for diuretic activity by using Mt from D. punctata. Both peptides stimulate fluid secretion in this species in a dose-dependent manner, with Dippu-DH31 and -DH46 having EC50 values of 9.8 nM and 13 nM, respectively. However, the maximal response to Dippu-DH31 is only 41% of that for Dippu-DH46 (Fig. 3A). Chicken calcitonin also stimulates secretion by D. punctata Mt in a dose-dependent manner (Fig. 3A), with an apparent EC50 of ≈380 nM, and a maximal stimulation perhaps higher than that of Dippu-DH46. However, these data had much more scatter than data for the other peptides, and a more limited range of concentrations was tested.
A dose–response curve was determined for Dippu-DH46 (Fig. 4A) with Mt exposed also to 1 nM Dippu-DH31 (only ≈1/10 of the EC50 value); the EC50 for Dippu-DH46 when assayed together with Dippu-DH31 decreased to 8.3 pM, ≈1000-fold lower than its EC50 in Fig. 3A. Similarly, the dose–response curve for Dippu-DH31 determined in the presence of 5 nM Dippu-DH46 (Fig. 4B; a concentration roughly 1/3 of its EC50 value) gave a combined EC50 value of 11 pM, again ≈1000-fold lower than its EC50 in Fig. 3A. The total fluid secretion was in this case obviously higher than the summed secretion of the two peptides.
Response of L. migratoria Mt to Dippu-DH31 and -DH46.
Although Mt of the orthopteran S. americana were used to monitor purification of Dippu-DH31, both this peptide and Dippu-DH46 were tested for activity on Mt of the related orthopteran L. migratoria, a far more characterized bioassay (3). Dippu-DH46 stimulated secretion maximally when compared with control tubules stimulated with Locmi-DH, and had an EC50 of 110 nM (95% confidence limits: 82–148 nM; Fig. 3B), a high concentration considering its 72% identity with Locmi-DH. On the other hand, Dippu-DH31 gave only 50% maximal stimulation, but had an EC50 of 0.56 nM (95% confidence limits: 0.51–0.64 nM; Fig. 3B).
When tested together at a variety of concentrations from threshold to EC50, the activities of these two peptides were additive rather than synergistic (data not shown), a markedly different result from that obtained with D. punctata Mt. In certain of these experiments, urine samples were taken for analysis of monovalent cation concentrations. Consistent with stimulation of urine production, DH increase the rate of transport of K+ and Na+ into the tubule lumen, the driving force for fluid secretion. Dippu-DH46 has a greater effect on the transport of Na+ than on K+, and the urine [K+]:[Na+] falls significantly (P < 0.0001) from 6.1 ± 0.3 (n = 6) in unstimulated tubules to 2.3 ± 0.3 (n = 6). In marked contrast, Dippu-DH31 has a nonselective effect on monovalent cation transport leaving the [K+]:[Na+] ratio virtually unchanged (5.3 ± 0.3; n = 6). The decrease in the urine [K+]:[Na+] ratio upon addition of Dippu-DH46 is consistent with the known action of Manse-DH on Mt of M. sexta. In this species, a Na+-K+-2Cl− cotransporter is stimulated by the action of this peptide at 5 nM concentration (21); a net influx of NaCl and KCl together would be expected to lower the [K+]:[Na+] ratio if the apical cation transporters have a preference for Na+ over K+, as shown in Rhodnius prolixus Mt (26).
Assay of D. punctata DH with pharmacological stimulants in Mt of L. migratoria.
To investigate the second-messenger systems involved in the response to the D. punctata DH, they were tested separately in combination with thapsigargin, an inhibitor of the endoplasmic reticulum Ca2+-ATPase used to raise intracellular levels of calcium, and with 8-bromo-cAMP, a membrane-permeant cAMP analogue. The effects of thapsigargin (1 μM) and Dippu-DH31 (0.5 nM) were additive (Fig. 5A), whereas the Ca2+-ATPase inhibitor acted cooperatively with Dippu-DH46 (200 nM), the combined response being significantly greater than the sum of their separate activities (Fig. 5B). In marked contrast, 8-bromo-cAMP (10 μM) produced an additive effect when tested with Dippu-DH46 (100 nM; Fig. 6B), but acted synergistically with 0.5 nM Dippu-DH31 (0.5 nM, Fig. 6A).
Interactions between diuretic peptides from L. migratoria and D. punctata in Mt of L. migratoria.
Two diuretic peptides from L. migratoria are known: Locmi-DH (CRF-related) acts via cAMP as second messenger, and locustakinin (Locmi-K), a myokinin (1), utilizes Ca2+ as second messenger. They act synergistically in stimulating urine production (24). Dippu-DH31 and -DH46 were tested in combination with one or the other of the L. migratoria peptides. The results are presented in Figs. 7 and 8. Dippu-DH31 acts synergistically with both Locmi-K (Fig. 7A) and Locmi-DH (Fig. 8A). On the other hand, Dippu-DH46 synergizes the effect of Locmi-K (Fig. 7B), but has no effect on the response to Locmi-DH (Fig. 8B).
Discussion
The sequences of Dippu-DH31 and -DH46 are remarkably different. Amino acid sequences of known insect CRF-like DH, plus sauvagine, urotensin I, urocortin, and CRF are shown in Fig. 2A. In this alignment, Dippu-DH46 is clearly a member of the CRF-related DH with high (83%) sequence identity to another cockroach DH, Peram-DP. However, Dippu-DH31 has very low similarity to other DH: only five residues are identical to those in Dippu-DH46 (Fig. 2A), and the C termini do not align. In the alignment shown in Fig. 2B, Dippu-DH31 has higher sequence identity to calcitonin (six residues identical with chicken and eel calcitonin, 19% sequence identity) than to any member of the CRF-like DH family of peptides. Dippu-DH31 lacks the disulfide bond between C-1 and C-7 of calcitonin; however, this disulfide ring is not important for biological activity of salmon calcitonin (27, 28). Moreover, we found chicken calcitonin to stimulate fluid flow in D. punctata Mt with EC50 of 380 nM (Fig. 3A), ≈40 times less potent than Dippu-DH31, further strengthening the identity of Dippu-DH31 as a calcitonin-like peptide.
Dippu-DH31 and -DH46 stimulate cAMP production in Mt, an action characteristic of both “long” and “short” CRF-like DH. However, in the fluid secretion assays, there was a clear distinction between the actions of the two DH, lending support to the contention that Dippu-DH31 is not a CRF-like DH family member.
Dippu-DH46 and Locmi-DH share 72% sequence identity and are identical in the region encompassing residues 7–11, previously implicated in signal transduction (29). Dippu-DH46 stimulates fluid secretion to the same extent as Locmi-DH in the locust diuretic assay, but the observed difference in EC50 value is high: this difference is consistent with the previously documented specificity of the L. migratoria receptor for binding (3). Dippu-DH46 and Locmi-DH differ most profoundly in a short region encompassing residues 29–35 (5 of the 6 residues differ). This region is a hypervariable region in the sequences of insect CRF-like DH and is believed to represent a loop region (30). The hypervariable region has little effect on the crossreactivity of the M. sexta DH receptor (3, 31), but may be important for receptor binding in L. migratoria and Acheta domesticus (3). The actions of Dippu-DH46 appear identical to those of Locmi-DH. Each acts additively with cAMP and synergistically with thapsigargin. Moreover, Dippu-DH46 promotes Na+ transport, resulting in the urine [K+]:[Na+] ratio being halved, and demonstrates synergism with Locmi-K, duplicating results obtained with Locmi-DH (24). The action of Dippu-DH46 may parallel that of Manse-DH in stimulating a Na+-K+-2Cl− cotransporter (21). The action of Culex salinarius-DP, or CCRF-DP, on Mt of a different mosquito species, Aedes aegypti, seems to constitute a different paradigm; at 1 nM concentration, it stimulates a paracellular Cl− conductance, whereas at 100 nM it stimulates transcellular active Na+ transport, together with passive Cl− conductance (13, 32). This paradigm may reflect a mechanistic difference between the CRF-like DH in phytophagous vs. hematophagous insects. Interestingly, the effect of CCRF-DP at nanomolar levels is characteristic of the actions of the kinins, which elevate intracellular Ca2+, whereas its actions at 100 nM are mimicked by dibutyryl-cAMP, typical of the other CRF-like DH.
Both Dippu-DH31 and -DH46 were isolated by monitoring elevation of secreted cAMP, but with synthetic replicates, both were characterized by using Ramsay assays, which test for actual diuretic activity. Assays were performed using Mt from both D. punctata and L. migratoria. Assays with cockroach tubules are extremely difficult, which is reflected in the higher SEM values seen in Fig. 3A (D. punctata) than in Fig. 3B (L. migratoria). We performed most studies on the actions of the two factors with L. migratoria Mt, because of the higher reproducibility of this assay and because Mt of S. americana were used for isolating Dippu-DH31. Dippu-DH31 increases fluid secretion by <50% of the response obtained with Dippu-DH46 in Ramsay assays with both L. migratoria and D. punctata Mt. The two peptides are about equipotent (EC50) on cockroach Mt, but, on locust Mt, Dippu-DH31 is >200 times more potent than Dippu-DH46. The potency of Dippu-DH31 on locust Mt is consistent with the use of grasshopper (S. americana) Mt for the isolation of Dippu-DH31, and suggests that orthopterans may use a similar DH as a circulating neurohormone. In marked contrast to the actions of Dippu-DH46, Dippu-DH31 acts additively with thapsigargin and synergistically with cAMP, results identical to those obtained previously with Locmi-K and other myokinins, although it lacks the characteristic C-terminal motif (FXXWG-NH2) of that peptide family. Moreover, in common with Locmi-K, Dippu-DH31 synergizes the effects of CRF-like DH, notably Dippu-DH46, in the cockroach assay, and synergizes the effects of Locmi-DH (but not of Dippu-DH46) in the locust assay. This paradoxical ability of Dippu-DH31 to synergize the effects of Locmi-DH, but not Dippu-DH46, in the locust probably reflects the high potency of Dippu-DH31 in this species (EC50 = 0.56 nM), whereas the potency of Dippu-DH46 is low (EC50 = 110 nM). The synergistic effect may be manifest only with a potent CRF-like DH; Locmi-DH has EC50 ≈1.7 nM (25) in this species.
We hypothesize that Dippu-DH31 acts in a manner similar to the diuretic kinins, namely by using an increase in intracellular calcium to open a Cl− conductance pathway. In support of this hypothesis, Dippu-DH31 has a nonselective effect on cation transport, leaving the urine [K+]:[Na+] ratio unchanged, as previously reported for Locmi-K and very different from the effect of CRF-like DH (see above). The differing molecular action would account for differences in the effects of Dippu-DH31 and -DH46 in the diuretic assays, and for their synergistic actions on D. punctata Mt. The synergistic effects of Dippu-DH31 and Locmi-K in the L. migratoria bioassay are harder to rationalize. In this context, it is noteworthy that Dippu-DH31 stimulates cAMP production in grasshopper Mt, the bioassay used for its isolation, whereas Locmi-K has no effect on this second messenger pathway.
To account for the apparent paradox between the elevation by Dippu-DH31 of cAMP in second messenger assays vs. its apparent action via Ca2+ in the fluid secretion assays, it is significant that several peptide hormones, including pituitary adenylyl cyclase activating peptide (PACAP) (33–36), calcitonin (37–39), and adipokinetic hormone (40), can elevate both the adenylyl cyclase and phosphoinositide pathways in their target tissues. Cell lines expressing a single, defined, recombinant calcitonin receptor show elevation of both cytosolic cAMP and Ca2+ upon ligand binding (38, 39). Furthermore, calcitonin has been shown to have cell cycle-specific effects in porcine kidney cells (LLC-PK1), elevating intracellular cAMP during the G1 phase, but activating the protein kinase C pathway in the S phase (37).
In conclusion, we have identified two DH from D. punctata that differ both in their sequences and in their mode of action. Dippu-DH46 is clearly a CRF-like DH and, like other peptides of this family, acts via a cAMP-dependent mechanism to stimulate cation (mainly Na+) transport. On the other hand, Dippu-DH31 appears to be a different type of peptide, more similar to vertebrate calcitonin than to CRF-like DH. Dippu-DH31 no doubt acts at receptors separate from those responding to Dippu-DH46 and appears to stimulate fluid secretion by a Ca2+-dependent mechanism.
Acknowledgments
We thank Dr. Houle Wang for mass spectral analyses, Prof. Iain Buxton for invaluable discussions, and Dr. M. J. O'Donnell for advice on the Ramsay assay in cockroaches. We gratefully acknowledge financial support from the National Institutes of Health (GM48172), Natural Sciences and Engineering Research Council (Canada) (OGP0009408), and the Nevada Agriculture Experiment Station.
Abbreviations
- CC
corpora cardiaca
- CRF
corticotropin-releasing factor (corticoliberin)
- DH
diuretic hormone
- DP
diuretic peptide
- Mt
Malpighian tubule
- TFA
trifluoroacetic acid
Note
The Drosophila melanogaster genome (42) encodes a peptide (TVDFGLARGYSGTQEAKHRMGLAAANFAGGP-NH2) that is 71% identical with Dippu-DH31, 87% if allowing for conservative substitutions. The sequence is preceded and followed by proper processing sites. Laenen (43) partially sequenced a putative diuretic peptide from the ant Formica polyctena. This peptide is identical with Dippu-DH31 in its 29 N-terminal residues, but the molecular mass is lower by 28 Da, showing it has a different C terminus. It would appear, therefore, that calcitonin-like DH are widespread in the Insecta.
Footnotes
References
- 1.Coast G M. Peptides. 1996;17:327–336. doi: 10.1016/0196-9781(95)02096-9. [DOI] [PubMed] [Google Scholar]
- 2.O'Donnell M J, Dow J A T, Huesmann G R, Tublitz N J, Maddrell S H P. J Exp Biol. 1996;199:1163–1175. doi: 10.1242/jeb.199.5.1163. [DOI] [PubMed] [Google Scholar]
- 3.Audsley N, Kay I, Hayes T K, Coast G M. Comp Biochem Physiol A Physiol. 1995;110A:87–93. doi: 10.1016/0300-9629(94)00132-d. [DOI] [PubMed] [Google Scholar]
- 4.Kataoka H, Troetschler R G, Li J P, Kramer S J, Carney R L, Schooley D A. Proc Natl Acad Sci USA. 1989;86:2976–2980. doi: 10.1073/pnas.86.8.2976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lehmberg E, Ota R B, Furuya K, King D S, Applebaum S W, Ferenz H-J, Schooley D A. Biochem Biophys Res Commun. 1991;179:1036–1041. doi: 10.1016/0006-291x(91)91923-z. [DOI] [PubMed] [Google Scholar]
- 6.Kay I, Coast G M, Cusinato O, Wheeler C H, Totty N F, Goldsworthy G J. Biol Chem Hoppe-Seyler. 1991;372:505–512. doi: 10.1515/bchm3.1991.372.2.505. [DOI] [PubMed] [Google Scholar]
- 7.Kay I, Wheeler C H, Coast G M, Totty N F, Cusinato O, Patel M, Goldsworthy G J. Biol Chem Hoppe-Seyler. 1991;372:929–934. doi: 10.1515/bchm3.1991.372.2.929. [DOI] [PubMed] [Google Scholar]
- 8.Kay I, Patel M, Coast G M, Totty N F, Mallet A I, Goldsworthy G J. Regul Pept. 1992;42:111–122. doi: 10.1016/0167-0115(92)90091-8. [DOI] [PubMed] [Google Scholar]
- 9.Blackburn M B, Kingan T G, Bodnar W, Shabanowitz J, Hunt D F, Kempe T, Wagner R M, Raina A K, Schnee M E, Ma M C. Biochem Biophys Res Commun. 1991;181:927–932. doi: 10.1016/0006-291x(91)92025-f. [DOI] [PubMed] [Google Scholar]
- 10.Clottens F L, Holman G M, Coast G M, Totty N F, Hayes T K, Kay I, Mallet A I, Wright M S, Chung J-S, Truong O, Bull D L. Peptides. 1994;15:971–979. doi: 10.1016/0196-9781(94)90059-0. [DOI] [PubMed] [Google Scholar]
- 11.Furuya K, Schegg K M, Wang H, King D S, Schooley D A. Proc Natl Acad Sci USA. 1995;92:12323–12327. doi: 10.1073/pnas.92.26.12323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Furuya K, Schegg K M, Schooley D A. Peptides. 1998;19:619–626. doi: 10.1016/s0196-9781(97)00475-0. [DOI] [PubMed] [Google Scholar]
- 13.Clark T M, Hayes T K, Beyenbach K W. Am J Physiol Renal Physiol. 1998;274:F834–F840. doi: 10.1152/ajprenal.1998.274.5.F834. [DOI] [PubMed] [Google Scholar]
- 14.Furuya K, Harper M, Schegg K M, Schooley D A. Insect Biochem Mol Biol. 2000;30:127–133. doi: 10.1016/s0965-1748(99)00106-x. [DOI] [PubMed] [Google Scholar]
- 15.Lovejoy D A, Balment R J. Gen Comp Endocrinol. 1999;115:1–22. doi: 10.1006/gcen.1999.7298. [DOI] [PubMed] [Google Scholar]
- 16.Spina M, Merlo-Pich E, Chan R K W, Basso A M, Rivier J, Vale W, Koob G F. Science. 1996;273:1561–1564. doi: 10.1126/science.273.5281.1561. [DOI] [PubMed] [Google Scholar]
- 17.Moreau J L, Kilpatrick G, Jenck F. Neuroreport. 1997;8:1697–1701. doi: 10.1097/00001756-199705060-00027. [DOI] [PubMed] [Google Scholar]
- 18.Szibbo C M, Tobe S S. Gen Comp Endocrinol. 1983;49:437–445. doi: 10.1016/0016-6480(83)90207-1. [DOI] [PubMed] [Google Scholar]
- 19.Yamamoto R T. J Econ Entomol. 1969;62:1427–1431. [Google Scholar]
- 20.King D S. ABRF News. 1996;7(4):26–28. [Google Scholar]
- 21.Audsley N, Coast G M, Schooley D A. J Exp Biol. 1993;178:231–243. [Google Scholar]
- 22.Ramsay J A. J Exp Biol. 1954;31:104–113. [Google Scholar]
- 23.Coast G M, Rayne R C, Hayes T K, Mallet A I, Thompson K S J, Bacon J P. J Exp Biol. 1993;175:1–14. doi: 10.1242/jeb.175.1.1. [DOI] [PubMed] [Google Scholar]
- 24.Coast G M. Regul Pept. 1995;57:283–296. doi: 10.1016/0167-0115(95)00042-A. [DOI] [PubMed] [Google Scholar]
- 25.Patel M, Hayes T K, Coast G M. J Exp Biol. 1995;198:793–804. doi: 10.1242/jeb.198.3.793. [DOI] [PubMed] [Google Scholar]
- 26.Maddrell S H P, O'Donnell M J. J Exp Biol. 1993;177:287–292. doi: 10.1242/jeb.177.1.273. [DOI] [PubMed] [Google Scholar]
- 27.Orlowski R C, Epand R M, Stafford A R. Eur J Biochem. 1987;162:399–402. doi: 10.1111/j.1432-1033.1987.tb10615.x. [DOI] [PubMed] [Google Scholar]
- 28.Yates A J, Gutierrez G E, Garrett I R, Mencel J J, Nuss G W, Schreiber A B, Mundy G R. Endocrinology. 1990;126:2845–2849. doi: 10.1210/endo-126-6-2845. [DOI] [PubMed] [Google Scholar]
- 29.Reagan J D. Insect Biochem Mol Biol. 1995;25:535–539. doi: 10.1016/0965-1748(95)00021-4. [DOI] [PubMed] [Google Scholar]
- 30.Copley K S, Welch W H, Schooley D A. Protein Society 10th Symposium. San Jose, CA: Cambridge Univ. Press; 1996. p. 99. [Google Scholar]
- 31.Reagan J D. J Biol Chem. 1994;269:9–12. [PubMed] [Google Scholar]
- 32.Clark T M, Hayes T K, Holman G M, Beyenbach K W. J Exp Biol. 1998;201:1753–1762. doi: 10.1242/jeb.201.11.1753. [DOI] [PubMed] [Google Scholar]
- 33.Gracia-Navarro F, Lamacz M, Tonon M C, Vaudry H. Endocrinology. 1992;131:1069–1074. doi: 10.1210/endo.131.3.1324148. [DOI] [PubMed] [Google Scholar]
- 34.Tatsuno I, Yada T, Vigh S, Hidaka H, Arimura A. Endocrinology. 1992;131:73–81. doi: 10.1210/endo.131.1.1319331. [DOI] [PubMed] [Google Scholar]
- 35.Yada T, Vigh S, Arimura A. Peptides. 1993;14:235–239. doi: 10.1016/0196-9781(93)90035-f. [DOI] [PubMed] [Google Scholar]
- 36.Hurwitz S. Crit Rev Biochem Mol Biol. 1996;31:41–100. doi: 10.3109/10409239609110575. [DOI] [PubMed] [Google Scholar]
- 37.Chakraborty M, Chatterjee D, Kellokumpu S, Rasmussen H, Baron R. Science. 1991;251:1078–1082. doi: 10.1126/science.1847755. [DOI] [PubMed] [Google Scholar]
- 38.Force T, Bonventre J V, Flannery M R, Gorn A H, Yamin M, Goldring S R. Am J Physiol. 1992;262:F1110–F1115. doi: 10.1152/ajprenal.1992.262.6.F1110. [DOI] [PubMed] [Google Scholar]
- 39.Chabre O, Conklin B R, Lin H Y, Lodish H F, Wilson E, Ives H E, Catanzariti L, Hemmings B A, Bourne H R. Mol Endocrinol. 1992;6:551–556. doi: 10.1210/mend.6.4.1316547. [DOI] [PubMed] [Google Scholar]
- 40.Arrese E L, Flowers M T, Gazard J L, Wells M A. J Lipid Res. 1999;40:556–564. [PubMed] [Google Scholar]
- 41.Thompson J D, Higgins D G, Gibson T J. Nucleic Acids Res. 1994;22:4673–4680. doi: 10.1093/nar/22.22.4673. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Adams M D, Celniker S E, Holt R A, Evans C A, Gocayne J D, Amanatides P G, Scherer S E, Li P W, Hoskins R A, Galle R F, et al. Science. 2000;287:2185–2195. doi: 10.1126/science.287.5461.2185. [DOI] [PubMed] [Google Scholar]
- 43.Laenen B. Ph.D. thesis. Belgium: Limburgs Universitair Centrum; 1999. [Google Scholar]